http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022099574-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3970ff2929243c84b2f197df598b9c59
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91caa8e15aac433aec4bc921a2173eab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7465c9af6b0f4bdc9851d62fbe84f486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8439df4d1abfe83c178f5a420737e980
publicationDate 2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022099574-A1
titleOfInvention Application of prazosin in preparation of drugs for treating and/or preventing cerebrovascular diseases
abstract An application of prazosin in preparation of drugs for treating and/or preventing cerebrovascular diseases, especially an application in preparation of drugs for treating cerebral ischemic stroke. The main mechanisms against ischemia evaluates the therapeutic effect of prazosin on cerebral ischemic stroke by using an MCAO cerebral ischemia-reperfusion injury animal model. The experiment result shows that prazosin has the effect of treating cerebral ischemic stroke, and can improve cerebral infarction to a greater extent compared with butylphthalide for clinical use. Prazosin realizes the effect against cerebral ischemia-reperfusion injury mainly by reducing the extent of oxidative stress damage, improving inflammatory reaction and inhibiting cell death, etc.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115317484-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115317484-B
priorityDate 2020-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13166
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25699
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30505
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1621
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID448806
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09172
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID31718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414359
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9XTA0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ68CI2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227006207
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61361
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4893
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64237

Total number of triples: 37.